71. Trehin,R. and Merkle,H.P. (2004) Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharm. Biopharm., 58, 209–223. 72. Tunnemann,G., Martin,R.M., Haupt,S., Patsch,C., Edenhofer,F. and Cardoso,M.C. (2006) Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J., 20, 1775–1784. 73. Barany-Wallje,E., Gaur,J., Lundberg,P., Langel,U. and Graslund,A. (2007) Diﬀerential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo. FEBS Lett., 581, 2389–2393. 74. El-Andaloussi,S., Jarver,P., Johansson,H.J. and Langel,U. (2007) Cargo-dependent cytotoxicity and delivery eﬃcacy of cell- penetrating peptides: a comparative study. Biochem. J., 407, 285–292. 75. Vives,E., Richard,J.P., Rispal,C. and Lebleu,B. (2003) TAT peptide internalization: seeking the mechanism of entry. Curr. Protein Pept. Sci., 4, 125–132. 76. Holliger,P. and Hudson,P.J. (2005) Engineered antibody fragments and the rise of single domains. Nat. Biotechnol., 23, 1126–1136. 77. Ruoslahti,E. (2004) Vascular zip codes in angiogenesis and metastasis. Biochem. Soc. Trans., 32, 397–402. 78. Brown,M.S. and Goldstein,J.L. (1986) A receptor-mediated path- way for cholesterol homeostasis. Science, 232, 34–47. 79. Hynes,R.O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell, 110, 673–687. 80. Juliano,R.L. (2002) Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu. Rev. Pharmacol. Toxicol., 42, 283–323. 81. Schlessinger,J. (2000) Cell signaling by receptor tyrosine kinases. Cell, 103, 211–225. 82. Armbruster,B.N. and Roth,B.L. (2005) Mining the receptorome. J. Biol. Chem., 280, 5129–5132. 83. Lundstrom,K. (2006) Latest development in drug discovery on G protein-coupled receptors. Curr. Protein Pept. Sci., 7, 465–470. 84. Akhtar,S., Basu,S., Wickstrom,E. and Juliano,R.L. (1991) Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes). Nucleic Acids Res., 19, 5551–5559. 85. Wittung,P., Kajanus,J., Edwards,K., Haaima,G., Nielsen,P.E., Norden,B. and Malmstrom,B.G. (1995) Phospholipid membrane permeability of peptide nucleic acid. FEBS Lett., 375, 27–29. 86. Juliano,R.L. (2005) Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA. Curr. Opin. Mol. Ther., 7, 132–136. 87. Abes,S., Moulton,H., Turner,J., Clair,P., Richard,J.P., Iversen,P., Gait,M.J. and Lebleu,B. (2007) Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice- correcting oligonucleotides. Biochem. Soc. Trans., 35, 53–55. 88. Astriab-Fisher,A., Sergueev,D., Fisher,M., Shaw,B.R. and Juliano,R.L. (2002) Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: eﬀects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res., 19, 744–754. 89. Astriab-Fisher,A., Sergueev,D.S., Fisher,M., Shaw,B.R. and Juliano,R.L. (2000) Antisense inhibition of P-glycoprotein expres- sion using peptide-oligonucleotide conjugates. Biochem. Pharmacol., 60, 83–90. 90. Muratovska,A. and Eccles,M.R. (2004) Conjugate for eﬃcient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett., 558, 63–68. 91. Chiu,Y.L., Ali,A., Chu,C.Y., Cao,H. and Rana,T.M. (2004) Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem. Biol., 11, 1165–1175. 92. Turner,J.J., Ivanova,G.D., Verbeure,B., Williams,D., Arzumanov,A.A., Abes,S., Lebleu,B. and Gait,M.J. (2005) Cell- penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucleic Acids Res., 33, 6837–6849. 93. El-Andaloussi,S., Johansson,H.J., Lundberg,P. and Langel,U. (2006) Induction of splice correction by cell-penetrating peptide nucleic acids. J. Gene Med., 8, 1262–1273. Nucleic Acids Research, 2008, Vol. 36, No. 12 4169 94. Bendifallah,N., Rasmussen,F.W., Zachar,V., Ebbesen,P., Nielsen,P.E. and Koppelhus,U. (2006) Evaluation of cell- penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconjug. Chem., 17, 750–758. 95. Moulton,H.M., Hase,M.C., Smith,K.M. and Iversen,P.L. (2003) HIV Tat peptide enhances cellular delivery of antisense morpho- lino oligomers. Antisense Nucleic Acid Drug Dev., 13, 31–43. 96. Abes,S., Turner,J.J., Ivanova,G.D., Owen,D., Williams,D., Arzumanov,A., Clair,P., Gait,M.J. and Lebleu,B. (2007) Eﬃcient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide. Nucleic Acids Res., 35, 4495–4502. 97. Fisher,A.A., Ye,D., Sergueev,D.S., Fisher,M.H., Shaw,B.R. and Juliano,R.L. (2002) Evaluating the speciﬁcity of antisense oligo- nucleotide conjugates. A DNA array analysis. J. Biol. Chem., 277, 22980–22984. 98. Turner,J.J., Arzumanov,A.A. and Gait,M.J. (2005) Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibi- tion activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides. Nucleic Acids Res., 33, 27–42. 99. Lundberg,P., El-Andaloussi,S., Sutlu,T., Johansson,H. and Langel,U. (2007) Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J., 21, 2664–2671. 100. Simeoni,F., Morris,M.C., Heitz,F. and Divita,G. (2003) Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res., 31, 2717–2724. 101. Veldhoen,S., Laufer,S.D., Trampe,A. and Restle,T. (2006) Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological eﬀect. Nucleic Acids Res., 34, 6561–6573. 102. Hu,J. and Corey,D.R. (2007) Inhibiting gene expression with peptide nucleic acid (PNA)—peptide conjugates that target chromosomal DNA. Biochemistry, 46, 7581–7589. 103. Moulton,H.M., Nelson,M.H., Hatlevig,S.A., Reddy,M.T. and Iversen,P.L. (2004) Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides. Bioconjug. Chem., 15, 290–299. 104. Wu,R.P., Youngblood,D.S., Hassinger,J.N., Lovejoy,C.E., Nelson,M.H., Iversen,P.L. and Moulton,H.M. (2007) Cell- penetrating peptides as transporters for morpholino oligomers: eﬀects of amino acid composition on intracellular delivery and cytotoxicity. Nucleic Acids Res., 35, 5182–5191. 105. Youngblood,D.S., Hatlevig,S.A., Hassinger,J.N., Iversen,P.L. and Moulton,H.M. (2007) Stability of cell-penetrating peptide- morpholino oligomer conjugates in human serum and in cells. Bioconjug. Chem., 18, 50–60. 106. Abes,R., Arzumanov,A.A., Moulton,H.M., Abes,S., Ivanova,G.D., Iversen,P.L., Gait,M.J. and Lebleu,B. (2007) Cell- penetrating-peptide-based delivery of oligonucleotides: an over- view. Biochem. Soc. Trans., 35, 775–779. 107. McNamara,J.O. II, Andrechek,E.R., Wang,Y., Viles,K.D., Rempel,R.E., Gilboa,E., Sullenger,B.A. and Giangrande,P.H. (2006) Cell type-speciﬁc delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol., 24, 1005–1015. 108. Chu,T.C., Twu,K.Y., Ellington,A.D. and Levy,M. (2006) Aptamer mediated siRNA delivery. Nucleic Acids Res., 34, e73. 109. Song,E., Zhu,P., Lee,S.K., Chowdhury,D., Kussman,S., Dykxhoorn,D.M., Feng,Y., Palliser,D., Weiner,D.B., Shankar,P. et al. (2005) Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol., 23, 709–717. 110. Peer,D., Zhu,P., Carman,C.V., Lieberman,J. and Shimaoka,M. (2007) Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc. Natl Acad. Sci. USA, 104, 4095–4100. 111. Tian,X., Aruva,M.R., Qin,W., Zhu,W., Sauter,E.R., Thakur,M.L. and Wickstrom,E. (2005) Noninvasive molecular imaging of MYC mRNA expression in human breast cancer xenografts with a [99mTc]peptide-peptide nucleic acid-peptide chimera. Bioconjug. Chem., 16, 70–79. 112. Cesarone,G., Edupuganti,O.P., Chen,C.P. and Wickstrom,E. (2007) Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA